The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?

We report a 75-year-old man with septic shock induced by ventilator-associated pneumonia caused by multiple drug-resistant Acinetobacter baumannii and catheter-related infection by vancomycin-resistant enterococci. He failed to respond to the initial management, including antibiotics (linezolid, imi...

Full description

Bibliographic Details
Main Authors: Po-Chin Chi, Chien-Liang Wu, Chung-Lieh Hung, Yu-Ling Weng, Ching-Chi Lin, Shih-Yi Lee
Format: Article
Language:English
Published: Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM) 2008-09-01
Series:International Journal of Gerontology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1873959808700504
_version_ 1818494705439080448
author Po-Chin Chi
Chien-Liang Wu
Chung-Lieh Hung
Yu-Ling Weng
Ching-Chi Lin
Shih-Yi Lee
author_facet Po-Chin Chi
Chien-Liang Wu
Chung-Lieh Hung
Yu-Ling Weng
Ching-Chi Lin
Shih-Yi Lee
author_sort Po-Chin Chi
collection DOAJ
description We report a 75-year-old man with septic shock induced by ventilator-associated pneumonia caused by multiple drug-resistant Acinetobacter baumannii and catheter-related infection by vancomycin-resistant enterococci. He failed to respond to the initial management, including antibiotics (linezolid, imipenem, sulbactam and colistin) and hemodynamic-guided fluid challenge. However, his condition improved dramatically after the antibiotic regimen was changed to tigecycline and ceftazidime. In addition to the superiority of the antibacterial effect of tigecycline, fluid control can be achieved more easily while using a single antibiotic instead of multiple drugs, which is also important for care of a critically ill elderly man with compromised cardiorespiratory or renal function. Here, we present a patient infected with multiple drug-resistant pathogens, who improved clinically after being treated with tigecycline, to demonstrate the benefits of this antibiotic.
first_indexed 2024-12-10T18:10:02Z
format Article
id doaj.art-ad87464437b84319a7f1f5581771dc4a
institution Directory Open Access Journal
issn 1873-9598
language English
last_indexed 2024-12-10T18:10:02Z
publishDate 2008-09-01
publisher Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)
record_format Article
series International Journal of Gerontology
spelling doaj.art-ad87464437b84319a7f1f5581771dc4a2022-12-22T01:38:30ZengTaiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)International Journal of Gerontology1873-95982008-09-012312412710.1016/S1873-9598(08)70050-4The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?Po-Chin Chi0Chien-Liang Wu1Chung-Lieh Hung2Yu-Ling Weng3Ching-Chi Lin4Shih-Yi Lee5Department of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanWe report a 75-year-old man with septic shock induced by ventilator-associated pneumonia caused by multiple drug-resistant Acinetobacter baumannii and catheter-related infection by vancomycin-resistant enterococci. He failed to respond to the initial management, including antibiotics (linezolid, imipenem, sulbactam and colistin) and hemodynamic-guided fluid challenge. However, his condition improved dramatically after the antibiotic regimen was changed to tigecycline and ceftazidime. In addition to the superiority of the antibacterial effect of tigecycline, fluid control can be achieved more easily while using a single antibiotic instead of multiple drugs, which is also important for care of a critically ill elderly man with compromised cardiorespiratory or renal function. Here, we present a patient infected with multiple drug-resistant pathogens, who improved clinically after being treated with tigecycline, to demonstrate the benefits of this antibiotic.http://www.sciencedirect.com/science/article/pii/S1873959808700504multiple antibacterial drug resistancetigecyclineventilator-associated pneumonia
spellingShingle Po-Chin Chi
Chien-Liang Wu
Chung-Lieh Hung
Yu-Ling Weng
Ching-Chi Lin
Shih-Yi Lee
The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?
International Journal of Gerontology
multiple antibacterial drug resistance
tigecycline
ventilator-associated pneumonia
title The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?
title_full The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?
title_fullStr The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?
title_full_unstemmed The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?
title_short The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?
title_sort experience of a novel glycylcycline antibiotic for a patient with infection caused by multiple drug resistant pathogens what is the benefit
topic multiple antibacterial drug resistance
tigecycline
ventilator-associated pneumonia
url http://www.sciencedirect.com/science/article/pii/S1873959808700504
work_keys_str_mv AT pochinchi theexperienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT chienliangwu theexperienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT chungliehhung theexperienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT yulingweng theexperienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT chingchilin theexperienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT shihyilee theexperienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT pochinchi experienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT chienliangwu experienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT chungliehhung experienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT yulingweng experienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT chingchilin experienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit
AT shihyilee experienceofanovelglycylcyclineantibioticforapatientwithinfectioncausedbymultipledrugresistantpathogenswhatisthebenefit